COVID-19 Trials in Santo André, Brazil
Conditions / COVID-19 / Santo André, Brazil
Research into COVID-19 spans multiple therapeutic approaches and trial phases.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | COMPLETED | PHASE3 |
| NCT04590586 | Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients | COMPLETED | PHASE3 |
| NCT04586153 | Study to Assess the Effect of Meplazumab on COVID-19 | COMPLETED | PHASE2/PHASE3 |
| NCT05047601 | A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection | COMPLETED | PHASE2/PHASE3 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) | COMPLETED | PHASE2/PHASE3 |
| NCT05298813 | Phase 1/2 Study to Evaluate the Efficacy and Safety of Inhaled IBIO123 in Participants With Mild to Moderate COVID-19 Illness | COMPLETED | PHASE1/PHASE2 |
| NCT05531149 | Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia | TERMINATED | PHASE3 |
| NCT04615949 | Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors | TERMINATED | — |
| NCT04402060 | A Study of APL-9 in Adults With Mild to Moderate ARDS Due to COVID-19 | COMPLETED | PHASE1/PHASE2 |
| NCT04421027 | A Study of Baricitinib (LY3009104) in Participants With COVID-19 | COMPLETED | PHASE3 |